IperionX Limited Sponsored ADR (NASDAQ:IPX) Receives $55.33 Average Price Target from Analysts

IperionX Limited Sponsored ADR (NASDAQ:IPX) has received a consensus rating of “Moderate Buy” from the six analysts that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $55.3333.

IPX has been the subject of a number of analyst reports. BTIG Research initiated coverage on shares of IperionX in a report on Friday, March 27th. They set a “buy” rating and a $40.00 target price for the company. B. Riley Financial lowered their target price on shares of IperionX from $58.00 to $52.00 and set a “buy” rating for the company in a report on Friday, March 13th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IperionX in a report on Tuesday, April 21st. Finally, Alliance Global Partners reaffirmed a “buy” rating on shares of IperionX in a report on Tuesday, April 28th.

Insider Buying and Selling at IperionX

In other news, Chairman Todd Hannigan purchased 260,000 shares of the firm’s stock in a transaction dated Wednesday, April 29th. The stock was bought at an average price of $4.20 per share, with a total value of $1,092,000.00. Following the acquisition, the chairman directly owned 26,108,334 shares of the company’s stock, valued at approximately $109,655,002.80. This represents a 1.01% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Anastasios Arima purchased 110,000 shares of the firm’s stock in a transaction dated Tuesday, April 28th. The stock was purchased at an average cost of $4.49 per share, with a total value of $493,900.00. Following the acquisition, the chief executive officer directly owned 12,316,782 shares in the company, valued at $55,302,351.18. This trade represents a 0.90% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought a total of 590,000 shares of company stock valued at $2,571,500 in the last three months.

Hedge Funds Weigh In On IperionX

Institutional investors and hedge funds have recently made changes to their positions in the company. Jones Financial Companies Lllp acquired a new position in shares of IperionX in the 3rd quarter valued at $36,000. JPMorgan Chase & Co. acquired a new position in shares of IperionX in the 2nd quarter valued at $66,000. State of Tennessee Department of Treasury acquired a new position in shares of IperionX in the 4th quarter valued at $119,000. DV Equities LLC acquired a new position in shares of IperionX in the 4th quarter valued at $178,000. Finally, Vanguard Personalized Indexing Management LLC acquired a new position in shares of IperionX in the 3rd quarter valued at $297,000. Institutional investors and hedge funds own 2.76% of the company’s stock.

IperionX Stock Performance

IPX opened at $34.70 on Friday. The company has a fifty day moving average price of $32.14 and a two-hundred day moving average price of $37.83. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03. IperionX has a 52 week low of $21.66 and a 52 week high of $61.45.

IperionX (NASDAQ:IPX) last released its earnings results on Saturday, January 31st. The company reported ($0.50) EPS for the quarter. On average, sell-side analysts forecast that IperionX will post -0.12 EPS for the current year.

About IperionX

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.